IMMUNOTHERAPY BASED ON DENDRITIC CELLS IN BLADDER CANCER TREATMENT
The development of an antitumor vaccine based on autologous dendritic cells (DCs) for bladder cancer treatment is extremely relevant today due to the proven high immunological potency of this type of tumor. Vaccination with DCs-based drugs as a monotherapy or in combination with other methods of tre...
Saved in:
| Main Authors: | A. S. Ilnitskaya, A. B. Danilova, I. A. Baldueva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2018-07-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current state and prospects of using dendritic cell vaccination for cancer immunotherapy
by: I.Yu. Filin, et al.
Published: (2022-09-01) -
Intratumoral Immunotherapy in Breast Cancer
by: Camille C. Baumrucker, et al.
Published: (2025-04-01) -
Advancements in bladder cancer immunotherapy: a focus on intravesical approaches
by: Xia Tang, et al.
Published: (2025-07-01) -
STUDY OF DENDRITIC CELL MIGRATION USING CELL-IQ ANALYSIS SYSTEM
by: T. L. Nekhaeva, et al.
Published: (2018-09-01) -
Neoantigen immunotherapy: a novel treatment for bladder cancer
by: Ruiyang Lv, et al.
Published: (2025-01-01)